Uterine Disorders Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Question | Answer |
Endometritis | infection of the endometrium, common after procedures or surgeries (C-section, D&E, D&C, IUD placement), polymicrobial, usually acute |
Acute endometritis s/s, diagnosis | elevated WBC count (neutrophils, esp.), uterine tenderness, fever, hx of procedure, may be foul-smelling vaginal d/c |
Acute endometritis treatment | hospitalize, IV abx |
Chronic endometritis treatment | doxycycline 100 mg po bid x 14 days |
Chronic endometritis diagnosis | endometrial bx |
Chronic endometritis s/s | asymptomatic; chronic irregular bleeding, pelvic pain, and d/c |
Pelvic inflammatory disease (PID) | infection of the female pelvic organs (bacterial); can be divided into endometritis and salpingitis, polymicrobial |
PID most common in: | young, sexually active, multiple partners |
2 bacteria most commonly responsible for PID | N. gonorrheae, C. trachomatis |
Minimum diagnostic criteria for PID | CMT or pelvic/adnexal pain + no other competing diagnosis; diagnosis is clinical |
PID clinical manifestations | chills/fever, adnexal/pelvic or abdominal pain, CMT, purulent d/c from os, abnormal bleeding, RUQ pain (if spread to the liver) |
PID effects | infertility, chronic pelvic pain, pelvic adhesions, ectopic pregnancy risk, dyspareunia |
Helpful diagnostic tests for PID | endocervical culture (always perform), wet prep (look for WBCs to indicate infx); do NOT wait to start treatment |
PID indications for hospital admission | HIV, tubo-ovarian abscess, patient cannot outpatient therapy, patient did not tolerate outpatient therapy, pregnancy, severe illness, N/V, high fever, was not able to r/o other surgical emergencies (eg appendicitis) |
PID outpatient treatment | ceftriaxone 250 mg IM + doxycycline 100 mg po bid x 14 days; can add metronidazole 500 mg po bid x 14 days |
Tubo-ovarian abscess | an abscess-like complex involving the Fallopian tube and ovary; a complication of PID |
Tubo-ovarian abscess presenting s/s | PID clinical menifestations, adnexal or rectouterine pouch mass or fullness, fever, leukocytosis |
Tubo-ovarian abscess diagnosis | US = test of choice |
Tubo-ovarian abscess treatment | hospitalize, IV abx, possible surgical extraction |
Endometrial hyperplasia | proliferation of the endometrium; occurs when simple proliferation advances to abnormal proliferation (involving stromal and glandular elements); common cause of AUB; can lead to and co-exist with endometrial cancer |
Endometrial hyperplasia cause | excess estrogen in the absence of progesterone; excess estrogen may be endogenous (adipose tissue) or exogenous (HRT without progesterone, oophorectomy) |
Endometrial hyperplasia is seen in: | perimenopause, menopause, obesity, HTN, DM, oligomenorrhea |
Endometrial hyperplasia histology | simple and complex (limited to architectural changes); atypical simple and complex (involves cellular changes, considered pre-malignant) |
Endometrial hyperplasia clinical presentation | often presents as long hx of amenorrhea or oligomenorrhea followed by AUB or excessive uterine bleeding |
Should always be considered cancer until proven otherwise: | uterine bleeding in postmenopausal women |
Endometrial hyperplasia diagnosis | endometrial biopsy = test of choice; US (evaluate endometrial stripe, more useful in postmenopausal); sonohysterography (evaluate focal patches or global growth) |
Atypical endometrial hyperplasia treatment | hysterectomy |
All forms of endometrial hyperplasia respond to: | progesterone |
Non-atypical endometrial hyperplasia treatment | continuous or cyclic progesterone (oral [Provera], injection [Depo-Provera], micronized vaginal progesterone [Prometrium], IUD [Mirena]); give x 3 months and then re-evaluate; may try D&C |
Who should be evaluated for endometrial hyperplasia or cancer: | > 40 y.o. w/AUB; < 40 y.o. w/AUB and (anovulation, obesity, tamoxifen use, DM, family hx of certain cancers); failed response to medical tx for AUB; cervical PAP findings that indicate evaluation of cervix |
Endometrial cancer | carcinoma of the endometrium, 4th most common cancer in American women |
Screening mechanism for endometrial cancer: | none |
75% of endometrial cancer occurs in: | postmenopausal women |
Prevention method for endometrial cancer: | premenopausal, anovulatory women (cyclic progesterones, OCPs, weight control); postmenopausal women (HRT with progesterone component) |
Type I endometrial cancer | most common (80%); usually due to excess endogenous or exogenous estrogen without progesterone; usually preceded by endometrial hyperplasia |
Type II endometrial cancer | estrogen-independent; not preceded by hyperplasia; more aggressive; poor prognosis; 20% of cases |
Endometrial cancer clinical manifestations | AUB, postmenopausal bleeding, may have vaginal d/c, adnexal masses, enlarged uterus, pain usually doesn't present until later stage |
Endometrial cancer diagnosis | endometrial bx |
Endometrial cancer treatment | refer, total abdominal hysterectomy and bilateral salpingo-oophorectomy, other options along with; follow up q 3-6 months x 2 years and then q year |
Created by:
Carrie D.
Popular Medical sets